Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BEVACIZUMAB-AWWB Cause Hypertension? 187 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 187 reports of Hypertension have been filed in association with BEVACIZUMAB-AWWB. This represents 4.5% of all adverse event reports for BEVACIZUMAB-AWWB.

187
Reports of Hypertension with BEVACIZUMAB-AWWB
4.5%
of all BEVACIZUMAB-AWWB reports
4
Deaths
13
Hospitalizations

How Dangerous Is Hypertension From BEVACIZUMAB-AWWB?

Of the 187 reports, 4 (2.1%) resulted in death, 13 (7.0%) required hospitalization, and 1 (0.5%) were considered life-threatening.

Is Hypertension Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB-AWWB. However, 187 reports have been filed with the FAERS database.

What Other Side Effects Does BEVACIZUMAB-AWWB Cause?

Off label use (441) Product storage error (437) Circumstance or information capable of leading to medication error (346) Blood pressure increased (163) Disease progression (160) Product dose omission issue (158) Adverse event (143) Platelet count decreased (118) Fatigue (104) Intercepted product administration error (97)

What Other Drugs Cause Hypertension?

ADALIMUMAB (9,032) METHOTREXATE (7,143) RITUXIMAB (6,760) PREDNISONE (6,087) INFLIXIMAB (5,874) ETANERCEPT (5,677) TOCILIZUMAB (5,492) ABATACEPT (5,114) TOFACITINIB (4,991) ALENDRONATE (4,373)

Which BEVACIZUMAB-AWWB Alternatives Have Lower Hypertension Risk?

BEVACIZUMAB-AWWB vs BEVACIZUMAB-BVZR BEVACIZUMAB-AWWB vs BEVACIZUMAB-MALY BEVACIZUMAB-AWWB vs BEXAROTENE BEVACIZUMAB-AWWB vs BEZAFIBRATE BEVACIZUMAB-AWWB vs BEZLOTOXUMAB

Related Pages

BEVACIZUMAB-AWWB Full Profile All Hypertension Reports All Drugs Causing Hypertension BEVACIZUMAB-AWWB Demographics